Correction for Morianos et al., Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways

IMMUNOLOGY AND INFLAMMATION Correction for “Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways,” by Ioannis Morianos, Aikaterini I. Trochoutsou, Gina Papadopoulou, Maria Semitekolou, Aggelos Banos, Dimitris Konstantopoulos, Antigoni Manousopoulou, Maria Kapasa, Ping Wei, Brett Lomenick, Elise Belaidi, Themis Kalamatas, Klinta Karageorgiou, Triantafyllos Doskas, Federica Sallusto, Fan Pan, Spiros D. Garbis, Francisco J. Quintana, and Georgina Xanthou, which was first published May 14, 2020; 10.1073/pnas.1918196117 (Proc. Natl. Acad. Sci. U.S.A. 117, 12269–12280).

The authors note that an additional affiliation should be listed for Federica Sallusto. The new affiliation should appear as Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland. The corrected author and affiliation lines appear below. The online version has been corrected.

Ioannis Morianos^a, Aikaterini I. Trochoutsou^a, Gina Papadopoulou^a, Maria Semitekolou^a, Aggelos Banos^b, Dimitris Konstantopoulos^c, Antigoni Manousopoulou^d, Maria Kapasa^e, Ping Wei^f, Brett Lomenick^g, Elise Belaidi^h,i, Themis Kalamatas^j, Klinta Karageorgiou^k, Triantafyllos Doskas^l, Federica Sallusto^m,n, Fan Pan^f, Spiros D. Garbis^g, Francisco J. Quintana^o,p, and Georgina Xanthou^a

^aCellular Immunology Laboratory, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece; ^bDivision of Immunobiology, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece; ^cDepartment of Molecular Biology and Genetics, Biomedical Sciences Research Center “Alexander Fleming”, 16672 Athens, Greece; ^dBeckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010; ^eMolecular Biology Laboratory, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece; ^fDepartment of Oncology and Medicine, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231; ^gProteome Exploration Laboratory, Beckman Institute, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125; ^hLaboratoire HP2, University Grenoble Alpes, F-38042 Grenoble, France; ⁱINSERM, U1042 Grenoble, France; ^jDepartment of Neurology, “G. Gennimatas” General State Hospital of Athens, 115 27 Athens, Greece; ^kDepartment of Neurology, Athens Medical Center, 151 25 Athens, Greece; ^lDepartment of Neurology, Athens Naval Hospital, 115 21 Athens, Greece; ^mInstitute of Microbiology, Eidgenössiche Technische Hochschule, 8093 Zürich, Switzerland; ⁿInstitute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland; ^oAnn Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and ^pThe Broad Institute of MIT and Harvard, Boston, MA 02115